• Moderna says its Covid-19 vaccine works against new variants
    New York, January 25 (IANS): US-based drugmaker Moderna on Monday said its Covid-19 vaccine retains neutralising activity against emerging variants first identified in the UK and South Africa. Vaccination with the Moderna Covid-19 Vaccine produced neutralising titers against all key emerging variants tested, including B.1.1.7 and B.1.351, first identified in the UK and South Africa, respectively, the company said on the basis of a study. However, the company also said it will tes
  • Moderna to make up to 125mn Covid-19 vaccine doses available globally
    New York Decèmber 4 (IANS): US-based drugmaker Moderna has said that it expects to have between 100 million and 125 million doses of its experimental Covid-19 vaccine available globally in the first quarter of 2021. Out of these, about 85-100 million doses will be made available in the US and 15-25 million doses will be available outside of the US, the company said on Thursday. These expected first quarter doses are inclusive within the 500 million to up to one billion dos
  • Q&A: Where are we in the COVID-19 vaccine race?
    Reuters Drugmakers and research centres around the world are working on COVID-19 vaccines, with large global trials of several of the candidates involving tens of thousands of participants well underway. The following is what we know about the race to deliver vaccines to help end the coronavirus pandemic that has claimed more than 1.34 million lives worldwide: Who is furthest along? U.S. drugmaker Pfizer Inc and German partner BioNTech SE released final late-stage trial da
  • Moderna COVID-19 vaccine to cost govts $25-$37 per dose: CEO
    Berlin, November 23 (IANS): Governments seeking to purchase Moderna's potential Covid-19 vaccine may have to shell out $25 and $37 per dose, depending on the size of the order, the company's CEO Stephane Bancel told German weekly 'Welt am Sonntag' (WamS). Bancel said that the price he quoted was a "fair price" and that the company was not interested in "maximum profit," according to the report on Sunday. The US pharma giant last week said that
  • 'Russia's Sputnik V to cost lower than Pfizer, Moderna's COVID vax'
    Moscow, November 22 (IANS): Russia's Sputnik V vaccine against Covid-19 will cost governments much lower than that of Pfizer's and Moderna's, the official Twitter handle of the world's first registered vaccine against the pandemic said on Sunday. "Translating pharma lingo: the announced price of Pfizer of $19.50 and Moderna of $25-$37 per dose actually means their price of $39 and $50-$74 per person. Two doses are required per person for the Pfizer, Sputnik